NovaBay Pharma's market cap is currently $14.17M. The company's EPS TTM is $-0.33; its P/E ratio is ―; NovaBay Pharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
